Preplanned secondary analysis of an RCT in COPD with chronic breathlessness (126/156 analysed): stopping low-dose sustained-release morphine vs placebo showed no significant difference in opioid withdrawal scores (day 1 median 2/60 vs 3/60); two on lower doses scored severe.
Secondary analysisn = 126
Currow et al. The Subjective Experiences of Ceasing Regular, Low-Dose, Sustained-Release Morphine when Treating Moderate to Severe Chronic Breathlessness